MX2019012738A - Peptido para inducir la regeneracion de tejido, y uso del mismo. - Google Patents
Peptido para inducir la regeneracion de tejido, y uso del mismo.Info
- Publication number
- MX2019012738A MX2019012738A MX2019012738A MX2019012738A MX2019012738A MX 2019012738 A MX2019012738 A MX 2019012738A MX 2019012738 A MX2019012738 A MX 2019012738A MX 2019012738 A MX2019012738 A MX 2019012738A MX 2019012738 A MX2019012738 A MX 2019012738A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- peptide
- tissue
- bone marrow
- inducing regeneration
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title 1
- 230000008929 regeneration Effects 0.000 title 1
- 238000011069 regeneration method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 210000001185 bone marrow Anatomy 0.000 abstract 3
- 230000005012 migration Effects 0.000 abstract 2
- 238000013508 migration Methods 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 101150038994 PDGFRA gene Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 1
- 230000001483 mobilizing effect Effects 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 210000002536 stromal cell Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se proporciona un péptido el cual se puede utilizar como un ingrediente activo de una composición para el uso en la estimulación de la migración de células positivas para PDGFRa, una composición para el uso en el reclutamiento de células madre mesenquimales de la médula ósea de la médula ósea hacia la sangre periférica, una composición para el uso en la regeneración de tejidos o una composición para el uso en la estimulación de la migración de células estromales derivadas de médula ósea.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017085793 | 2017-04-25 | ||
| PCT/JP2018/016654 WO2018199107A1 (ja) | 2017-04-25 | 2018-04-24 | 組織再生を誘導するためのペプチドとその利用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019012738A true MX2019012738A (es) | 2020-02-07 |
Family
ID=63918419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012738A MX2019012738A (es) | 2017-04-25 | 2018-04-24 | Peptido para inducir la regeneracion de tejido, y uso del mismo. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210163552A1 (es) |
| EP (1) | EP3617222A4 (es) |
| JP (1) | JP7113007B2 (es) |
| KR (1) | KR102681936B1 (es) |
| CN (1) | CN110612307B (es) |
| AU (1) | AU2018257071B2 (es) |
| BR (1) | BR112019021230A2 (es) |
| CA (1) | CA3059544A1 (es) |
| MX (1) | MX2019012738A (es) |
| SG (1) | SG11201909851SA (es) |
| WO (1) | WO2018199107A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118460462A (zh) | 2017-12-01 | 2024-08-09 | 斯特姆里姆有限公司 | 外胚层间充质干细胞及其产生方法 |
| US20210024594A1 (en) | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| EP3865179B1 (en) * | 2018-10-25 | 2025-07-23 | The University of Osaka | Hmgb1 derived peptide for treating or preventing a cartilage disorder |
| US20230241159A1 (en) * | 2020-04-03 | 2023-08-03 | StemRIM Inc. | Peptide Having Mesenchymal Stem Cell Mobilizing Activity |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE424416T1 (de) | 2002-07-03 | 2009-03-15 | San Raffaele Centro Fond | Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung |
| KR101249287B1 (ko) * | 2004-09-03 | 2013-04-01 | 크리어빌리스 쎄라퓨틱스 에스.피.에이. | 인간 및 비인간 ｈｍｇｂ１ ｂｏｘａ의 단백질분해효소내성 돌연변이 및 그들의 치료／진단 용도 |
| WO2007015546A1 (ja) | 2005-08-04 | 2007-02-08 | Genomix Co., Ltd | 間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法 |
| US7829097B2 (en) * | 2006-02-06 | 2010-11-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of HMGB1 for protection against ischemia reperfusion injury |
| HUE035043T2 (en) | 2006-10-30 | 2018-05-02 | Genomix Co Ltd | A pharmaceutical composition for promoting functional regeneration of damaged tissue |
| KR20110027665A (ko) | 2008-04-30 | 2011-03-16 | 가부시키가이샤 제노믹스 | 손상조직의 기능적 재생 촉진 의약 |
| US8673580B2 (en) | 2008-04-30 | 2014-03-18 | Genomix Co., Ltd. | Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| RU2571230C2 (ru) | 2008-04-30 | 2015-12-20 | Дженомикс Ко., Лтд. | Способ сбора функциональных клеток in vivo с высокой эффективностью |
| RU2016135937A (ru) * | 2009-10-28 | 2018-12-11 | Дженомикс Ко., Лтд. | Средства для стимуляции регенерации тканей путем привлечения мезинхимных стволовых клеток и/или плюрипотентных стволовых клеток костного мозга в кровь |
| DK3358011T3 (da) * | 2011-04-26 | 2020-05-11 | Univ Osaka | Peptid til inducering af regenerering af væv og anvendelse deraf |
| ES2661500T3 (es) * | 2012-07-26 | 2018-04-02 | Ospedale San Raffaele S.R.L. | Variantes de HMGB1 y sus usos |
| ES2660420T3 (es) * | 2012-10-25 | 2018-03-22 | Genomix Co., Ltd. | Método novedoso para tratar infarto cardiaco utilizando fragmento de HMGB1 |
-
2018
- 2018-04-24 CA CA3059544A patent/CA3059544A1/en active Pending
- 2018-04-24 AU AU2018257071A patent/AU2018257071B2/en not_active Ceased
- 2018-04-24 BR BR112019021230-2A patent/BR112019021230A2/pt unknown
- 2018-04-24 CN CN201880027706.3A patent/CN110612307B/zh active Active
- 2018-04-24 EP EP18791294.4A patent/EP3617222A4/en not_active Withdrawn
- 2018-04-24 JP JP2019514543A patent/JP7113007B2/ja active Active
- 2018-04-24 US US16/608,139 patent/US20210163552A1/en not_active Abandoned
- 2018-04-24 WO PCT/JP2018/016654 patent/WO2018199107A1/ja not_active Ceased
- 2018-04-24 MX MX2019012738A patent/MX2019012738A/es unknown
- 2018-04-24 SG SG11201909851S patent/SG11201909851SA/en unknown
- 2018-04-24 KR KR1020197033427A patent/KR102681936B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019137603A (ru) | 2021-05-25 |
| CA3059544A1 (en) | 2018-11-01 |
| SG11201909851SA (en) | 2019-11-28 |
| BR112019021230A2 (pt) | 2020-06-02 |
| AU2018257071A1 (en) | 2019-10-31 |
| EP3617222A1 (en) | 2020-03-04 |
| JPWO2018199107A1 (ja) | 2020-02-27 |
| KR102681936B1 (ko) | 2024-07-04 |
| AU2018257071B2 (en) | 2021-11-11 |
| US20210163552A1 (en) | 2021-06-03 |
| KR20190141179A (ko) | 2019-12-23 |
| RU2019137603A3 (es) | 2021-07-05 |
| EP3617222A4 (en) | 2021-01-20 |
| CN110612307A (zh) | 2019-12-24 |
| JP7113007B2 (ja) | 2022-08-04 |
| CN110612307B (zh) | 2023-02-14 |
| WO2018199107A1 (ja) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019012738A (es) | Peptido para inducir la regeneracion de tejido, y uso del mismo. | |
| MX2020006128A (es) | Inhibidores de la proteina de activacion de fibroblastos. | |
| EP3735978A4 (en) | COMPOSITION FOR IMPROVING, PREVENTING OR TREATING DISEASES OF THE SKIN CONSISTING OF A MESENCHYMATIC STEM CELL DERIVED FROM AN INDUCED PLURIPOTENT STEM CELL AND AN EXOSOME DERIVED THEREOF | |
| PH12018502056A1 (en) | Methods of treatment of cholestatic diseases | |
| MX2016016756A (es) | Terapia con células madre en patologías endometriales. | |
| IL274538B (en) | A preparation containing mesenchymal stem cells for tissue regeneration and a method for its production | |
| MX390493B (es) | Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas | |
| IL287649A (en) | A method for treating tooth bearing disease using growth factors and exosomes of characterized mesenchymal stem cells | |
| MY185691A (en) | An asseointegrable device | |
| WO2014165723A3 (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
| PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
| BR112018008931A8 (pt) | ?compostos para tratamento de distúrbios hipoproliferativos? | |
| MX2019014867A (es) | Metodo para tratar un efecto secundario de la inmunoterapia. | |
| TW201613569A (en) | Composition consisting of kukoamine A and/or kukoamine B and method of using thereof | |
| WO2015159308A3 (en) | Osteoinductive formulation and preparation thereof | |
| WO2019027299A3 (ko) | 간세포성장인자를 발현하는 중간엽줄기세포를 유효성분으로 포함하는 혈관계 질환 예방 또는 치료용 약학 조성물 | |
| WO2018085516A3 (en) | Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases | |
| ZA202007320B (en) | Compounds for pain treatment, compositions comprising same, and methods of using same | |
| ZA202005083B (en) | Solid forms of fasoracetam | |
| EP3773486C0 (en) | MESENCHYMAL STROMAL CELLS DERIVED FROM UMBILICAL CORD TISSUE USED IN THE TREATMENT OF AUTISTIC SPECTRUM DISORDERS | |
| PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
| MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. | |
| TW201614066A (en) | Composition for treatment of joint disease and method thereof | |
| GEAP202014778A (en) | Combination of trazodone and gabapentin for the treatmen | |
| MY173966A (en) | A cell-based composition and use thereof for treatment of acute stroke |